Westlake Omics operates as an artificial intelligence (AI)-empowered micro-world data company operating in the biotechnology sector. The company's main services include the use of proteomics and multimodal big data to aid in precision medicine and drug research and development. Westlake Omics primarily serves the healthcare and pharmaceutical industries. It was founded in 2020 and is based in Hangzhou, China.